1. Home
  2. GFAI vs INAB Comparison

GFAI vs INAB Comparison

Compare GFAI & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.55

Market Cap

19.4M

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$2.32

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFAI
INAB
Founded
2018
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
10.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GFAI
INAB
Price
$0.55
$2.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.50
$108.00
AVG Volume (30 Days)
360.1K
684.0K
Earning Date
09-23-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,987,715.00
N/A
Revenue This Year
$5.66
N/A
Revenue Next Year
$4.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.38
N/A
52 Week Low
$0.57
$1.17
52 Week High
$3.88
$12.53

Technical Indicators

Market Signals
Indicator
GFAI
INAB
Relative Strength Index (RSI) 29.29 65.76
Support Level $0.57 $1.17
Resistance Level $0.80 $2.24
Average True Range (ATR) 0.06 0.24
MACD -0.02 0.10
Stochastic Oscillator 4.39 98.54

Price Performance

Historical Comparison
GFAI
INAB

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: